Select Publications
Journal articles
2004, 'Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia', Proceedings of the National Academy of Sciences of the United States of America, 101, pp. 12604 - 12609, http://dx.doi.org/10.1073/pnas.0405077101
,2004, 'Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain', Neuroscience, 127, pp. 125 - 136, http://dx.doi.org/10.1016/j.neuroscience.2004.04.026
,2004, 'Postmortem investigations of the pathophysiology of schizophrenia: The role of susceptibility genes', Journal of Psychiatry and Neuroscience, 29, pp. 287 - 293
,2004, 'Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus', Neuropsychopharmacology, 29, pp. 1063 - 1069, http://dx.doi.org/10.1038/sj.npp.1300422
,2004, 'Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia', Neurochemical Research, 29, pp. 1245 - 1255, http://dx.doi.org/10.1023/B:NERE.0000023611.99452.47
,2004, 'Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain', Archives of General Psychiatry, 61, pp. 544 - 555, http://dx.doi.org/10.1001/archpsyc.61.6.544
,2004, 'Estradiol Alters Transcription Factor Gene Expression in Primate Prefrontal Cortex', Journal of Neuroscience Research, 76, pp. 306 - 314, http://dx.doi.org/10.1002/jnr.20076
,2004, 'Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia', Molecular Psychiatry, 9, pp. 299 - 307, http://dx.doi.org/10.1038/sj.mp.4001434
,2004, 'High-Level Expression of Dok-1 in Neurons of the Primate Prefrontal Cortex and Hippocampus', Journal of Neuroscience Research, 75, pp. 218 - 224, http://dx.doi.org/10.1002/jnr.10842
,2004, 'Glutamate Carboxypeptidase II Gene Expression in the Human Frontal and Temporal Lobe in Schizophrenia', Neuropsychopharmacology, 29, pp. 117 - 125, http://dx.doi.org/10.1038/sj.npp.1300304
,2004, 'Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: Molecular evidence for a pathology of dendritic spines', American Journal of Psychiatry, 161, pp. 1848 - 1855, http://dx.doi.org/10.1176/ajp.161.10.1848
,2004, 'Reduced GSK-alpha mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients.', Journal of Neural Transmission, 111, pp. 1583 - 1592, http://dx.doi.org/10.1007/s00702-004-0166-3
,2003, 'Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development', Molecular Psychiatry, 8, pp. 797 - 810, http://dx.doi.org/10.1038/sj.mp.4001319
,2003, 'Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation', European Journal of Neuroscience, 18, pp. 1197 - 1205, http://dx.doi.org/10.1046/j.1460-9568.2003.02850.x
,2003, 'Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia', Molecular Psychiatry, 8, pp. 592 - 610, http://dx.doi.org/10.1038/sj.mp.4001308
,2003, 'Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia', Neuropsychopharmacology, 28, pp. 1521 - 1530, http://dx.doi.org/10.1038/sj.npp.1300218
,2003, 'Catechol O-methyltransferase mRNA expression in human and rat brain: Evidence for a role in cortical neuronal function', Neuroscience, 116, pp. 127 - 137, http://dx.doi.org/10.1016/S0306-4522(02)00556-0
,2003, 'Epidermal growth factor receptor expression is related to post-mitotic events in cerebellar development: Regulation by thyroid hormone', Developmental Brain Research, 140, pp. 1 - 13, http://dx.doi.org/10.1016/S0165-3806(02)00539-4
,2003, 'Changes in NMDA Receptor Subunit mRNAs and Cyclophilin mRNA during Development of the Human Hippocampus', Annals of the New York Academy of Sciences, 1003, pp. 426 - 430, http://dx.doi.org/10.1196/annals.1300.043
,2003, 'Gene expression in dopamine and GABA systems in an animal model of schizophrenia: Effects of antipsychotic drugs', European Journal of Neuroscience, 18, pp. 391 - 402, http://dx.doi.org/10.1046/j.1460-9568.2003.02738.x
,2002, 'Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan', European Journal of Neuroscience, 15, pp. 269 - 280, http://dx.doi.org/10.1046/j.0953-816x.2001.01858.x
,2002, 'BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex', Developmental Brain Research, 139, pp. 139 - 150, http://dx.doi.org/10.1016/S0165-3806(02)00540-0
,2002, 'Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders', Molecular Psychiatry, 7, pp. 985 - 994, http://dx.doi.org/10.1038/sj.mp.4001139
,2001, 'Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia', Schizophrenia Research, 49, pp. 89 - 98, http://dx.doi.org/10.1016/S0920-9964(00)00052-9
,2001, 'Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus', Biological Psychiatry, 49, pp. 528 - 539, http://dx.doi.org/10.1016/S0006-3223(00)00968-9
,2001, 'BDNF mRNA expression in rat hippocampus and prefrontal cortex: Effects of neonatal ventral hippocampal damage and antipsychotic drugs', European Journal of Neuroscience, 14, pp. 135 - 144, http://dx.doi.org/10.1046/j.1460-9568.2001.01633.x
,2001, 'Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia', Cerebral Cortex, 11, pp. 136 - 147, http://dx.doi.org/10.1093/cercor/11.2.136
,2000, 'Differential DNA damage in response to the neonatal and adult excitotoxic hippocampal lesion in rats', European Journal of Neuroscience, 12, pp. 4424 - 4433, http://dx.doi.org/10.1046/j.0953-816X.2000.01320.x
,2000, 'Localization of epidermal growth factor receptors and putative neuoblasts in human subependymal zone', Journal of Comparative Neurology, 423, pp. 359 - 372, http://dx.doi.org/10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0
,1999, 'The weaver GIRK2 mutation leads to decreased levels of serum thyroid hormone: Characterization of the effect on midbrain dopaminergic neuron survival', Experimental Neurology, 160, pp. 413 - 424, http://dx.doi.org/10.1006/exnr.1999.7231
,1998, 'A candidate molecule approach to defining developmental pathology in schizophrenia', Schizophrenia Bulletin, 24, pp. 303 - 316, http://dx.doi.org/10.1093/oxfordjournals.schbul.a033327
,1998, 'The neuroanatomy and neurochemistry of schizophrenia', Psychiatric Clinics of North America, 21, pp. 57 - 75, http://dx.doi.org/10.1016/S0193-953X(05)70361-0
,1997, 'Neuropathology of suicide. A review and an approach', Annals of the New York Academy of Sciences, 836, pp. 201 - 219, http://dx.doi.org/10.1111/j.1749-6632.1997.tb52361.x
,1995, 'Striatal TGF-α: postnatal developmental expression and evidence for a role in the proliferation of subependymal cells', Developmental Brain Research, 86, pp. 203 - 216, http://dx.doi.org/10.1016/0165-3806(95)00026-A
,1995, 'GDNF mRNA expression in normal postnatal development, aging, and in weaver mutant mice', Neurobiology of Aging, 16, pp. 925 - 929, http://dx.doi.org/10.1016/0197-4580(95)02011-X
,1995, 'Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes', NeuroReport, 6, pp. 1454 - 1458, http://dx.doi.org/10.1097/00001756-199507100-00023
,Conference Papers
2021, 'Stratifying by Inflammatory Status Reveals Novel Neuropathology in Neurogenic Niche in Schizophrenia', in NEUROPSYCHOPHARMACOLOGY, SPRINGERNATURE, pp. 61 - 62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000725511400131&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Alterations in the Kynurenine Pathway in Depression With and Without Psychosis', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, NY, New York, pp. S248 - S248, presented at 75th Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), NY, New York, 30 April 2020 - 02 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000535308200603&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Peripheral Inflammation Markers Identify a Subset of Patients With Schizophrenia and Related Psychoses who Display Intellectual Decline From Premorbid Levels', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, NY, New York, pp. S319 - S319, presented at 75th Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), NY, New York, 30 April 2020 - 02 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000535308201022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'ELEVATION OF MACROPHAGE-RELATED TRANSCRIPTS IN THE MIDBRAIN IN SCHIZOPHRENIA', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, ITALY, Florence, pp. S27 - S28, presented at Congress of the Schizophrenia-International-Research-Society (SRIS), ITALY, Florence, 04 April 2020 - 08 April 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000537751800059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'INCREASED INFLAMMATION AND MACROPHAGE INFILTRATION IS ASSOCIATED WITH ALTERED SUBEPENDYMAL ZONE NEUROGENESIS IN SCHIZOPHRENIA BUT NOT BIPOLAR DISORDER', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, ITALY, Florence, pp. S28 - S29, presented at Congress of the Schizophrenia-International-Research-Society (SRIS), ITALY, Florence, 04 April 2020 - 08 April 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000537751800062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'INVESTIGATING THE BEST PREDICTIVE CLINICAL FEATURES OF ANTI-N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ENCEPHALITIS IN THE 2010 AUSTRALIAN NATIONAL SURVEY OF HIGH IMPACT PSYCHOSIS (SHIP) COHORT', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, ITALY, Florence, pp. S172 - S173, presented at Congress of the Schizophrenia-International-Research-Society (SRIS), ITALY, Florence, 04 April 2020 - 08 April 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000537751800385&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'PERIPHERAL INFLAMMATION MARKERS IDENTIFY SUBSET OF PATIENTS WITH SCHIZOPHRENIA AND RELATED PSYCHOSES WHO HAVE INTELLECTUAL DECLINE FROM PREMORBID LEVELS', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, ITALY, Florence, pp. S158 - S158, presented at Congress of the Schizophrenia-International-Research-Society (SRIS), ITALY, Florence, 04 April 2020 - 08 April 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000537751800352&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Reduction in Peripheral C-Reactive Protein Levels With Canakinumab Administration is Related to Reduced Positive Symptom Severity in Patients With Schizophrenia and Inflammation', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, pp. S176 - S177, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000509546600338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'The Pharmacogenomics of Clozapine-Induced Myocarditis (PROCLAIM) Consortium', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, pp. S479 - S480, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000509546600873&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'C-Reactive Protein as a Marker of Inflammation in Acute Psychosis and Schizophrenia', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, CA, San Diego, pp. S312 - S313, presented at 72nd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), CA, San Diego, 18 May 2017 - 20 May 2017, http://dx.doi.org/10.1016/j.biopsych.2017.02.837
,2017, 'Efficacy of Transcranial Direct Current Stimulation in Unipolar and Bipolar Depression: Results from an International Randomized Controlled Trial', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, CA, San Diego, pp. S30 - S31, presented at 72nd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), CA, San Diego, 18 May 2017 - 20 May 2017, http://dx.doi.org/10.1016/j.biopsych.2017.02.084
,2017, 'Evidence for Blood-Brain Barrier Disruption and Antibody Presence in Brains of People with Schizophrenia', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, CA, San Diego, pp. S311 - S312, presented at 72nd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), CA, San Diego, 18 May 2017 - 20 May 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000400348700764&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'Increased C3 and C4 Proteins in Serum of FEP and UHR Patients: Implications for Inflammatory Subtyping in SCZ', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, CA, San Diego, pp. S27 - S28, presented at 72nd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), CA, San Diego, 18 May 2017 - 20 May 2017, http://dx.doi.org/10.1016/j.biopsych.2017.02.077
,2016, 'Lower Brain pH as a Shared Endophenotype of Psychiatric Disorders', in NEUROPSYCHOPHARMACOLOGY, NATURE PUBLISHING GROUP, pp. S410 - S411, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440365600687&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,